Midkine positively regulates the proliferation of human gastric cancer cells

Cancer Letters

Volumn 279, Issue 2, 2009, Pages 137-144

  Xu, Yingying ^a   Qu, Xiujuan ^a   Zhang, Xue ^a   Luo, Yang ^a   Zhang, Ye ^a   Luo, Ying ^a   Hou, Kezuo ^a   Liu, Yunpeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Cell cycle; ERK1 2; Gastric cancer; Midkine

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MIDKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NERVE GROWTH FACTORS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 67349262480     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.024     Document Type: Article

References (42)

1. Alberts S.R., Cervantes A., and van de Velde C.J. Gastric cancer: epidemiology, pathology and treatment. Ann. Oncol. 14 (2003) 31-36
2. Lee J.H., Kim S.H., Wang L.H., Choi Y.L., Kim Y.C., Kim J.H., Park T.S., Hong T.S., Hong Y.C., and Shin Y.K. Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clin. Cancer Res. 13 (2007) 2584-2591
3. Wu Y.L., Zhang S., Wang G.R., and Chen Y.P. Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. World J. Gastroenterol. 14 (2008) 4943-4948
4. Cervantes A., Rodríguez Braun E., Pérez Fidalgo A., and Chirivella González I. Molecular biology of gastric cancer. Clin. Transl. Oncol. 9 (2007) 208-215
5. Aaronson S.A. Growth factors and cancer. Science 254 (1991) 1146-1153
6. Ren Y.J., and Zhang Q.Y. Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World J. Gastroenterol. 12 (2006) 2006-2010
7. Tao P., Xu D., Lin S., Ouyang G.L., Chang Y., Chen Q., Yuan Y., Zhuo X., Luo Q., Li J., Li B., Ruan L., Li Q., and Li Z. Abnormal expression, highly efficient detection and novel truncations of midkine in human tumors, cancers and cell lines. Cancer Lett. 253 (2007) 60-67
8. Ikematsu S., Yano A., Aridome K., Kikuchi M., Kumai H., Nagano H., Okamoto K., Oda M., Sakuma S., Aikou T., Muramatsu H., Kadomatsu K., and Muramatsu T. Serum midkine levels are increased in patients with various types of carcinomas. Br. J. Cancer 83 (2000) 701-706
9. Soulié P., Héroult M., Bernard-Pierrot I., Caruelle D., Oglobine J., Barritault D., and Courty J. Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients. Cancer Detect. Prev. 28 (2004) 319-324
10. Ikematsu S., Okamoto K., Yoshida Y., Oda M., Sugano-Nagano H., Ashida K., Kumai H., Kadomatsu K., Muramatsu H., Takashi M., and Sakuma S. High levels of urinary midkine in various cancer patients. Biochem. Biophys. Res. Commun. 306 (2003) 329-332
11. Obata Y., Kikuchi S., Lin Y., Yagyu K., Muramatsu T., and Kumai H. Serum midkine concentrations and gastric cancer. Cancer Sci. 96 (2005) 54-56
12. Huang Y., Cao G., Wang H., Wang Q., and Hou Y. The expression and location of midkine in gastric carcinomas of Chinese patients. Cell Mol. Immunol. 4 (2007) 135-140
13. Ishimoto H., Muench M.O., Higuchi T., Minegishi K., Tanaka M., Yoshimura Y., and Jaffe R.B. Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland. J. Clin. Endocrinol. Metab. 91 (2006) 4050-4056
14. Chen S., Bu G., Takei Y., Sakamoto K., Ikematsu S., Muramatsu T., and Kadomatsu K. Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J. Cell Sci. 120 (2007) 4009-4015
15. Horiba M., Kadomatsu K., Yasui K., Lee J.K., Takenaka H., Sumida A., Kamiya K., Chen S., Sakuma S., Muramatsu T., and Kodama I. Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 114 (2006) 1713-1720
16. Sakaguchi N., Muramatsu H., Ichihara-Tanaka K., Maeda N., Noda M., Yamamoto T., Michikawa M., Ikematsu S., Sakuma S., and Muramatsu T. Receptor-type protein tyrosine phosphatase zeta as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons. Neurosci. Res. 45 (2003) 219-224
17. You Z., Dong Y., Kong X., Beckett L.A., Gandour-Edwards R., and Melamed J. Midkine is a NF-kappaB-inducible gene that supports prostate cancer cell survival. BMC Med. Genom. 14 (2008) 1-6
18. Ohuchida T., Okamoto K., Akahane K., Higure A., Todoroki H., Abe Y., Kikuchi M., Ikematsu S., Muramatsu T., and Itoh H. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Cancer 100 (2004) 2430-2436
19. Kadomatsu K., Hagihara M., Akhter S., Fan Q.W., Muramatsu H., and Muramatsu T. Midkine induces the transformation of NIH3T3 cells. Br. J. Cancer 75 (1997) 354-359
20. Stoica G.E., Kuo A., Powers C., Bowden E.T., Sale E.B., Riegel A.T., and Wellstein A. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J. Biol. Chem. 277 (2002) 35990-35998
21. Kadomatsu K. The midkine family in cancer, inflammation and neural development. Nagoya J. Med. Sci. 67 (2005) 71-82
22. Friedrich C., Holtkamp N., Cinatl Jr. J., Sakuma S., Mautner V.F., Wellman S., Michaelis M., Henze G., Kurtz A., and Driever P.H. Overexpression of midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency. Int. J. Oncol. 27 (2005) 1433-1440
23. Sandra F., Harada H., Nakamura N., and Ohishi M. Midkine induced growth of ameloblastoma through MAPK and Akt pathways. Oral Oncol. 40 (2004) 274-280
24. Jin Z., Lahat G., Korchin B., Nguyen T., Zhu Q.S., Wang X., Lazar A.J., Trent J., Pollock R.E., and Lev D. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin. Cancer Res. 14 (2008) 5033-5042
25. Ratovitski E.A., Kotzbauer P.T., Milbrandt J., Lowenstein C.J., and Burrow C.R. Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases. J. Biol. Chem. 273 (1998) 3654-3660
26. Cernkovich E.R., Deng J., Hua K., and Harp J.B. Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells. Endocrinology 148 (2007) 1598-1604
27. Wang Q.L., Wang H., Zhao S.L., Huang Y.H., and Hou Y.Y. Over-expressed and truncated midkines promote proliferation of BGC823 cells in vitro and tumor growth in vivo. World J. Gastroenterol. 14 (2008) 1858-1865
28. Aridome K., Tsutsui J., Takao S., Kadomatsu K., Ozawa M., Aikou T., and Muramatsu T. Increased midkine gene expression in human gastrointestinal cancers. Jpn. J. Cancer Res. 86 (1995) 655-661
29. Joseph P., Lei Y.X., Whong W.Z., and Ong T.M. Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res. 62 (2002) 703-707
30. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., and Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262 (1993) 695-700
31. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell Mol. Med. 9 (2005) 59-71
32. Koistinaho M., and Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40 (2002) 175-183
33. Wang Q., Huang Y., Ni Y., Wang H., and Hou Y. siRNA targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase3,8,9 activation and mitochondrial depolarization. J. Biomed. Sci. 14 (2007) 783-795
34. Tong Y., Mentlein R., Buhl R., Hugo H.H., Krause J., Mehdorn H.M., and Held-Feindt J. Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas. J. Neurochem. 100 (2007) 1097-1107
35. del Peso L., González-García M., Page C., Herrera R., and Nuñez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278 (1997) 687-689
36. Fang X., Yu S., Eder A., Mao M., Bast Jr. R.C., Boyd D., and Mills G.B. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene 18 (1999) 6635-6640
37. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
38. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., Franklin R.A., and McCubrey J.A. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17 (2003) 590-603
39. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., Amenomori M., Shibagaki I., Nakao K., Ikenaga M., et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54 (1994) 3107-3110
40. Walker D.H., and Maller J.L. Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature 354 (1991) 314-317
41. Diehl J.A., Cheng M., Roussel M.F., and Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12 (1998) 3499-3511
42. Meloche S., and Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26 (2007) 3227-3239